Main Menu

ICR and Imperial Convergence Science PhD programme

Main Round - December 2020

Applications for our cross-institutional PhD studentships are now closed

The Institute of Cancer Research and Imperial College London are pleased to announce that funding is available for our non-clinical Convergence Science PhD Programme. Studentships will be for four years commencing in October 2021. Applications for PhDs are invited from talented UK graduates or final year undergraduates. International students are also invited to apply subject to outlining how they will meet the difference in tuition fees. We look forward to receiving applications from all candidates and will select those who display the potential to become the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome UK applicants from Black and ethnic minority backgrounds, as they are underrepresented at PhD level within the ICR and Imperial.

Candidates should hold, or expect to gain, either;

  • A first, or upper-second class honours degree (or equivalent) in a relevant subject.
  • A masters degree in a relevant subject.

Successful candidates will undertake a four-year research training programme under the guidance of a supervisory team of world-class researchers. Students receive an annual stipend, currently £21,000 per annum, and project costs paid for the four-year duration. Convergence Science PhDs cover tuition fees for UK students only.  Funding for overseas fees is not provided.

Four cross-institutional PhD projects are listed below. All are jointly supervised by the ICR and Imperial College London supervisors. You can find details of the eligibility criteria, instructions on how to apply, and the important dates at the end of the project list.

 


Studentships Available (4)


 

[1] PROJECT: Engineering next generation targeted cancer immunotherapy

Application menu title: Targeted cancer immunotherapy

The student will be registered at Imperial College, leading to the award of a PhD from Imperial College London

View project proposal


 

[2] PROJECT: Molecular barcodes for high-dimensional functionalization of cancer heterogeneity

Application menu title: Molecular barcodes for functionalization of cancer heterogeneity

The student will be registered at Imperial College, leading to the award of a PhD from Imperial College London

View project proposal

 

 

[3] PROJECT: Accelerating volumetric MR Imaging for Real-Time Adaptive Radiotherapy

Application menu title: Accelerating volumetric MR Imaging for Real-Time Adaptive Radiotherapy

The student will be registered at the Institute of Cancer Research, leading to the award of a PhD from the University of London

View project proposal


 

[4] PROJECT: Spatial and temporal high resolution quantitative live imaging techniques to determine mechanisms of chromosomal instability and drug resistance in breast cancer patient-derived organoids

Application menu title: Live imaging techniques to determine mechanisms of chromosomal drug resistance in breast cancer

The student will be registered at the Institute of Cancer Research, leading to the award of a PhD from the University of London

View project proposal


 

Eligibility and application information

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff and students.

Applications for our ICR and Imperial Convergence Science PhD programme are made online via the ICR's Student Application Portal.

 

Important dates:

  • Applications for our ICR/Imperial Convergence Science PhD studentships Main Round opened on 10 December 2020
  • Applications will close on Sunday 03 January 2021 at 11:55pm UK time. Your referees should have submitted references by 10 January 2021.
  • Remote/online video-based panel interviews will be held on February 03 2021

How to apply

 


Register your interest for future PhD studentships

Other studentships outside of the ICR's main PhD recruitment round may be advertised throughout the year. These studentships have a separate application process. 

To register your interest for future PhD studentship opportunities, please email [email protected].

 


 

Previously advertised studentships

The deadline for applications for these projects was 22 November 2020. 

New Formulations of Anticancer Drugs for Targeted Treatment of Triple Negative Breast Cancers. Professor Alexandra PorterDepartment of MaterialsProfessor Spiros LinardopoulosCancer Therapeutics. Registered at the ICR. View project proposal

Magnetic Resonance detection of functionalized extracellular vesicles to understand their role in breast cancer development and metastasis formationProfessor Molly StevensDepartment of MaterialsDr Simon RobinsonRadiotherapy and Imaging. Registered at the ICR. View project proposal

Novel Bio-Chips for real-time detection of acidification in the tumour microenvironment. Dr Pantelis GeorgiouDepartment of Electrical and Electronic EngineeringProfessor Chris BakalCancer Biology Registered at Imperial College. College. View project proposal

Combined functional MRI and super-resolution ultrasound for non-invasive monitoring of tumour blood delivery during breast cancer radiotherapy. Professor Mengxing TangDepartment of BioengineeringDr Navita SomaiahRadiotherapy and Imaging. Registered at Imperial College. View project proposal

New Formulations of Anticancer Drugs for Targeted Treatment of Triple Negative Breast Cancers. Professor Alexandra PorterDepartment of MaterialsProfessor Spiros LinardopoulosCancer Therapeutics. Registered at the ICR. View project proposal

Magnetic Resonance detection of functionalized extracellular vesicles to understand their role in breast cancer development and metastasis formation. Professor Molly StevensDepartment of MaterialsDr Simon Robinson,Radiotherapy and Imaging. Registered at the ICR. View project proposal

 

PhD studentships

Applications for our main PhD studentships recruitment round are now closed.

ICR values

Our values – developed together as an organisation – make it clear how each and every one of us work to meet our mission – to make the discoveries that defeat cancer.